BOVIMUN MAST

COMPOSITION

• One dose of te vaccine (5.0 ml) contains:
• Active components (prior to inactivation):
• Streptococcus agalactiae, strain St.ag-19 ≥ 8.0 lg CFU
• Streptococcus uberis, strain St.ub-19 ≥ 8.0 lg CFU
• Staphylococcus aureus, strain Staph.au-19 ≥ 8.0 lg CFU
• Escherichia coli, strain UA J5≥ 9.0 lg CFU

PHARMACEUTICAL FORM

• Suspension.

IMMUNOBIOLOGCAL PROPERTIES

• In vaccinated animals, 8-10 days after double administration, a protective immune response is formed to the above-mentioned pathogens of infectious mastitis, which persists for up to 6 months.
• Vaccinated cows transmit immunoglobulins through colostrum, which protect newborn calves from these infectious agents.

ANIMAL SPECIES

• Cattle.

INDICATIONS FOR USE

• Prevention of clinical and subclinical mastitis of cattle, exacerbation of subclinical forms of mastitis and their conversion into a clinical form for treatment, as well as for the prevention of postpartum endometritis caused by these pathogens.

CONTRAINDICATIONS

• No contraindications.

PRECAUTIONS FOR USE

• Before use, the vaccine is heated to a temperature of 20-25°C and shaken thoroughly.
• It is not allowed to vaccinate clinically sick and exhausted animals.